The association between melanosis coli and the use of cathartics that contain the active ingredient, anthraquinone, has been established
This shift reflects a more mature interpretation of the evidence: the risk is not uniform across all GLP-1 users
Pharmaceutical companies that manufacture intravenous glutathione have a marketing agenda and pursue dermatologists to administer this drug to such patients
This reduces the risk of hypoglycaemia compared to some other diabetes medicines, though the risk increases when used alongside insulin or sulfonylureas
Kruse-Lsler B, Gaertner C, Brger H, Seper L, Joos U, Kleinheinz J (2006) Melanotic neuroectodermal tumor of infancy: systematic review of the literature and presentation of a case
You said you've been using this product for a while